DOI: 10.1039/d6ra03199d ISSN: 2046-2069
Inhibition of amyloid β aggregation by venetoclax: a computational and in vitro experimental approach
Bei-bei Liu, He-cheng Wang, Yi-le He, Liu-jie Zhang, Dong-li Meng, Yun Fu, Ming-yong Wang, Wei ZhangVenetoclax, as a repurposed therapeutic candidate for Alzheimer's disease, inhibits Aβ42 aggregation, alleviates Aβ-induced neurotoxicity.